Use of DNA Microarrays to Monitor Host Response to Virus and Virus-Derived Gene Therapy Vectors

Author： Stefania Piersanti   Yuri Martina   Gioia Cherubini   Daniele Avitabile   Isabella Saggio  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.4, Iss.6, 2004-01, pp. : 345-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 385-394

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 478-491

Bentham Science Publishers

Access to resources Recommend Favorite

From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy

By  

Current Gene Therapy, Vol. 3, Iss. 4, 2003-01 ,pp. : 281-304

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Biosafety of Virus-Derived Vectors (Guest Editor: William Moens)]

By  

Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Replicating herpes simplex virus vectors for cancer gene therapy

By Yeung S.N.   Tufaro F.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite